Contents: (Small 1/2017)
Source abstract
Abstract
Antiamyloidogenic agents have promising application potential in AD therapies. In article number 1602857, L. Zhu, Z. Hu, Y. Yang, and co-workers present an A42binding agent amyloid inhibitory 1 (AIP1), demonstrate its inhibitory effect on A42 oligomerization and fibrillation, and show that AIP1 rescue A42-induced cytotoxicity through decreasing A42 oligomer content is related to cell membrane permeability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polydiacetylene-based materials and applications · Advanced Nanomaterials in Catalysis · Alzheimer's disease research and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.